No Picture
Trading Ideas

Goldman Sachs: 3 High-Yield Dividend Stocks With Growth on the Horizon

Did the bull market cycle end on September 2? The NASDAQ lost 7% from its peak above 12,000, while the S&P saw smaller losses of 4.5%. Of course, there have been positive trading sessions – and a look at the year-to-date chart suggests that stock markets simply experienced a temporary correction, one of several that have occurred so far, since the bull run began in March.Still, the market activity of the past two weeks reminds us that every investor should take steps to defend his portfolio, in good times as well as bad. Banking giant Goldman Sachs has taken that …read more […]

No Picture
Trading Ideas

‘Cuties’ Backlash Led Netflix U.S. Cancellations to Spike Nearly Eightfold, Analytics Firm Says

A campaign waged against Netflix over “Cuties” and the film’s sexualized portrayal of children produced a surge in U.S. subscription cancellations over the weekend, according to research company YipitData. Netflix subscriber churn rates began to rise Sept. 10, the day after the release of “Cuties” on Netflix, when the hashtag “CancelNetflix” was in the top-trending […] …read more […]

No Picture
Trading Ideas

Hedge Funds Dipping Their Toes Back Into Royal Caribbean Cruises Ltd. (RCL)

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). We reversed our stance on March 25th after seeing unprecedented fiscal and monetary stimulus unleashed by the Fed and the Congress. […] …read more […]

No Picture
Trading Ideas

BioNTech wins $445 million German grant for COVID-19 vaccine

German biotech firm BioNTech said on Tuesday it had secured almost $450 million in government funding to speed up work on its COVID-19 vaccine candidate and expand its production capacity in Germany. BioNTech and partners Pfizer Inc and China’s Shanghai Fosun Pharmaceutical Group Co Ltd are among the leading developers of experimental COVID-19 vaccines, based on molecules carrying a genetic code called messenger RNA (mRNA). Mainz-based BioNTech, founded in 2008 and listed on the Nasdaq exchange last year, said it had been awarded 375 million euros ($445 million) in funding, after applying under a scheme announced in July …read more […]

No Picture
Trading Ideas

Vanguard faults Alphabet on CEO pay, names new proxy chief

Vanguard Group Inc said it voted against the pay of Alphabet Inc executives, including new CEO Sundar Pichai, one of several examples of proxy voting the top mutual fund firm gave in a report to be released on Tuesday as it names a new stewardship chief. Vanguard said in the report it “found a misalignment between pay and performance” and would have liked to see more long-term compensation tied to metrics like relative total shareholder return. An Alphabet spokeswoman declined to comment on Vanguard’s votes. …read more […]